Oral News and Research

RSS

Researchers to highlight impact of maternal glycemia on childhood obesity at The Pregnancy Meeting

In a study to be presented on Feb. 5 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the impact of maternal glycemia on childhood obesity and metabolic dysfunction.

3 Feb 2015

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.

2 Feb 2015

U.S. Supreme Court to hear arguments in landmark case aiming at Affordable Care Act

On March 4, the U.S. Supreme Court will hear oral arguments in King v. Burwell, a landmark case that takes aim at President Obama's Affordable Care Act (ACA).

2 Feb 2015

ACP, other health care organizations urge Supreme Court to uphold premium subsidies created by ACA

The American College of Physicians today - along with other health care organizations - submitted an amicus curiae (friend of the court) brief to the Supreme Court of the United States in the King v. Burwell case, urging the court to uphold the premium subsidies created by the Affordable Care Act in all states.

2 Feb 2015

Project Spark to advance neuroprotective drug for schizophrenia-associated cognitive impairment

A public-private consortium led by the biotech Iproteos -based at Parc Científic de Barcelona (PCB)-, and comprised by the biopharmaceutical company Ascil-Biopharma, the Institute for Biomedical Research (IRB Barcelona), the Centre for Genomic Regulation (CRG) and the University of the Basque Country (UPV/EHU) has launched a project to advance the development of a new neuroprotective drug for the treatment of the cognitive impairment associated with schizophrenia and other mental disorders.

31 Jan 2015

AbbVie releases Phase 3 results from all-oral OBV/PTV/r treatment for GT1b chronic HCV infection

AbbVie released top-line Phase 3 results for its investigational, all-oral, ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir (OBV/PTV/r) in patients with genotype 1b (GT1b) chronic hepatitis C virus (HCV) infection in Japan.

31 Jan 2015

Micromotor fueled by stomach acid effectively delivers gold nanoparticles

Researchers at the University of California, San Diego have shown that a micromotor fueled by stomach acid can take a bubble-powered ride inside a mouse. These tiny motors, each about one-fifth the width of a human hair, may someday offer a safer and more efficient way to deliver drugs or diagnose tumors.

31 Jan 2015

Nomogram aids management of boys with constitutional delay in growth and puberty

A puberty nomogram is better than the classical criteria for identifying boys with constitutional delay in growth and puberty, report researchers.

30 Jan 2015

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

ANI Pharmaceuticals, Inc. today announced the launch of Etodolac 300mg oral capsules, indicated for use in the management of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and acute pain.

30 Jan 2015

K. Hovnanian Children's Hospital introduces Meridian Dentistry for Children

K. Hovnanian Children's Hospital at Jersey Shore University Medical Center introduces Meridian Dentistry for Children, a specialized, full-service, dental practice for infants, children and adolescents in a child-friendly, caring environment.

30 Jan 2015

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

The farnesoid-X receptor (FXR), also known as the chief regulator of bile acid metabolism, is thought to play a role in some hepatobiliary and gastrointestinal disorders.

30 Jan 2015

Study: Green tea compound may activate a cycle that kills oral cancer cells

A compound found in green tea may trigger a cycle that kills oral cancer cells while leaving healthy cells alone, according to Penn State food scientists. The research could lead to treatments for oral cancer, as well as other types of cancer.

28 Jan 2015

Long-term TDF therapy offers sustained HBV suppression without resistance

Patients with chronic hepatitis B virus infection can achieve sustained viral suppression with long-term tenofovir disoproxil fumarate treatment without developing resistance, shows a 7-year study.

28 Jan 2015

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

A new range of vitamins and food supplements developed to enhance the health of specific organs has been launched in the UK.

28 Jan 2015

Study provides new route for treating patients with difficult-to-treat Parkinson's symptoms

Parkinson's disease patients treated with low-frequency deep brain stimulation show significant improvements in swallowing dysfunction and freezing of gait over typical high-frequency treatment.

28 Jan 2015

Developmental salivary biomarkers linked to feeding success in newborns

Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.

28 Jan 2015

TSRI scientists find drug candidates that can prevent degeneration of brain cells in Parkinson's

In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease.

28 Jan 2015

Bronchial thermoplasty for severe asthma: an interview with Dr. Rob Niven

Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.

27 Jan 2015

Neuromod Devices, Irish Tinnitus Association announce launch of Tinnitus Awareness Week 2015

Saturday 31st of January sees the launch of Tinnitus Awareness Week. This year a public event will take place, hosted by The Neuromod Clinic in conjunction with the Irish Tinnitus Association. This free of charge event will take place at The Hermitage Medical Clinic, Lucan, Dublin at 10.30am on Saturday the 31st January.

27 Jan 2015

Morphine after tonsillectomy may be life threatening for children

Treating post-operative pain with morphine can cause life-threatening respiratory problems in some children who have had their tonsils and/or adenoids removed, new research has found.

27 Jan 2015

Oral News and Research

Researchers to highlight impact of maternal glycemia on childhood obesity at The Pregnancy Meeting

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

U.S. Supreme Court to hear arguments in landmark case aiming at Affordable Care Act

ACP, other health care organizations urge Supreme Court to uphold premium subsidies created by ACA

Project Spark to advance neuroprotective drug for schizophrenia-associated cognitive impairment

AbbVie releases Phase 3 results from all-oral OBV/PTV/r treatment for GT1b chronic HCV infection

Micromotor fueled by stomach acid effectively delivers gold nanoparticles

Nomogram aids management of boys with constitutional delay in growth and puberty

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

K. Hovnanian Children's Hospital introduces Meridian Dentistry for Children

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

Study: Green tea compound may activate a cycle that kills oral cancer cells

Long-term TDF therapy offers sustained HBV suppression without resistance

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

Study provides new route for treating patients with difficult-to-treat Parkinson's symptoms

Developmental salivary biomarkers linked to feeding success in newborns

TSRI scientists find drug candidates that can prevent degeneration of brain cells in Parkinson's

Bronchial thermoplasty for severe asthma: an interview with Dr. Rob Niven

Neuromod Devices, Irish Tinnitus Association announce launch of Tinnitus Awareness Week 2015

Morphine after tonsillectomy may be life threatening for children

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News